MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Co-Diagnostics Inc

Slēgts

SektorsVeselības aprūpe

0.28

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.24

Max

0.28

Galvenie mērījumi

By Trading Economics

Ienākumi

3.5M

-7.5M

Pārdošana

-99K

50K

EPS

-0.257

Peļņas marža

-14,983.533

Darbinieki

132

EBITDA

4.3M

-7.2M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+257.14% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 7. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-2M

9.4M

Iepriekšējā atvēršanas cena

0.28

Iepriekšējā slēgšanas cena

0.28

Ziņu noskaņojums

By Acuity

68%

32%

334 / 375 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

Co-Diagnostics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 5. jūl. 04:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 4. jūl. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 4. jūl. 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 4. jūl. 20:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 4. jūl. 20:50 UTC

Tirgus saruna

Energy & Utilities Roundup: Market Talk

2025. g. 4. jūl. 16:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 4. jūl. 16:20 UTC

Tirgus saruna

Energy & Utilities Roundup: Market Talk

2025. g. 4. jūl. 16:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 4. jūl. 16:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 4. jūl. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 4. jūl. 15:57 UTC

Tirgus saruna

Base Metal Prices Fall in Thin, Risk-off Trading -- Market Talk

2025. g. 4. jūl. 15:49 UTC

Tirgus saruna

Gold Futures Set to End Week Flat After Mixed Jobs Report -- Market Talk

2025. g. 4. jūl. 15:49 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole: Deal Will Have a Negative Impact of Approximately 30 Basis Points on the Fully-Loaded CET1 Ratio

2025. g. 4. jūl. 15:49 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole: Transaction Is Consistent With Targets in Terms of Return of Investment, Return on Tangible Equity

2025. g. 4. jūl. 15:49 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole Received All Required Authorizations

2025. g. 4. jūl. 15:48 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole: CACEIS and Santander Are Maintaining Their Long-Term Partnership

2025. g. 4. jūl. 15:47 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole: Agreement Was Announced on Dec. 19

2025. g. 4. jūl. 15:47 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole Now Controls 100% of the Share Capital of CACEIS

2025. g. 4. jūl. 15:46 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole Completes Acquisition of Santander's 30.5% Stake in CACEIS

2025. g. 4. jūl. 14:30 UTC

Iegādes, apvienošanās, pārņemšana

Rocky Shore Closes Hemlo Area Claims Sale to Barrick Mining Unit for C$975,000 Cash

2025. g. 4. jūl. 13:53 UTC

Tirgus saruna

Polish Zloty Faces Hit From Prospect of Further Rate Cuts -- Market Talk

2025. g. 4. jūl. 13:41 UTC

Tirgus saruna

Japanese Yen Could Receive Boost From Increased Rate-Hike Bets -- Market Talk

2025. g. 4. jūl. 13:41 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 4. jūl. 13:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 4. jūl. 12:37 UTC

Tirgus saruna

Fund Manager Roundup: U.S. Treasurys in Focus Amid Rising Debt

2025. g. 4. jūl. 12:37 UTC

Tirgus saruna

Fund Manager Roundup: U.S. Treasurys in Focus -2-

2025. g. 4. jūl. 12:30 UTC

Tirgus saruna

Fund Manager Roundup: U.S. Tariff Deadline Key for Dollar Outlook, U.K. Fiscal Risks In Focus for Pound

2025. g. 4. jūl. 12:15 UTC

Tirgus saruna

Targeted Tariffs Would Likely Support Dollar -- Market Talk

2025. g. 4. jūl. 12:13 UTC

Tirgus saruna

Further Pause in Tariffs Would Have Unclear Impact on Dollar -- Market Talk

2025. g. 4. jūl. 12:02 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Co-Diagnostics Inc Prognoze

Cenas mērķis

By TipRanks

257.14% augšup

Prognoze 12 mēnešiem

Vidējais 1 USD  257.14%

Augstākais 1 USD

Zemākais 1 USD

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Co-Diagnostics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

1 ratings

0

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

0.3495 / 0.3699Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Weak Bearish Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

334 / 375 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.